Neurocritical Care

Microcirculatory ischemia

Protein catabolism in severe critical illness/immobility may cause muscle wasting.

Sepsis

Multiorgan dysfunction

Hyperglycemia

Neuromuscular blockade

Duration of vasopressor or corticosteroid therapy

Duration of ICU stay

Limb and diaphragm weakness may persist for weeks to months.

or breathe.

No specific treatments have been shown effective.

Intensive glycemic control may reduce critical illness neuropathy.

Passive mobilization/early physical therapy in the ICU

Daily awakening/less time on the ventilator

Limiting risk factors as much as possible

1.11 cases per 100,000 person-years

Bilateral symmetric progressive weakness of limbs

Nerve conduction studies may provide a more precise diagnosis.

Typically associated with Campylobacter jejuni infection. Also associated with Epstein-Barr virus,

varicella-zoster, and Mycoplasma pneumoniae infections

has not been associated with other seasonal influenza vaccines.

Progressive weakness over 3–4 weeks

Mortality rate around 5%